The Vienna General Hospital, usually abbreviated to AKH, is the general hospital of the city of Vienna, Austria. It is also the city's university hospital, and the site of the Medical University of Vienna. It is Europe's fifth largest hospital, both by number of employees and bed capacity.

There are 2,200 beds in AKH, Klinik für Urologie der Universität Wien.

During the past decade, AKH, Klinik für Urologie der Universität Wien conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "AKH, Klinik für Urologie der Universität Wien" are "Bladder Cancer" (2 trials). Many other conditions were trialed in "AKH, Klinik für Urologie der Universität Wien" in a lesser frequency.

Most popular intervention types in "AKH, Klinik für Urologie der Universität Wien" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Hexvix" (1 trials) and "Standard white light cystoscopy" (1 trials). Other intervention names were less common.

The vast majority of trials in "AKH, Klinik für Urologie der Universität Wien" are 2 trials for "All" genders.

Currently, there are NaN active trials in "AKH, Klinik für Urologie der Universität Wien". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in AKH, Klinik für Urologie der Universität Wien, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AKH, Klinik für Urologie der Universität Wien, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".